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ABSTRACT 
The kidney is considered the most important organ of excretion eliminating the body 
from metabolic waste products. The nephron is the functional unit of the kidney, 
composed of a cluster of capillaries named glomerulus, and a tubular system. The blood 
is filtered in the glomerular capillaries across the glomerular filtration barrier. The 
barrier is an intricate biological structure composed of the inner capillary endothelial 
cells, the glomerular basement membrane, and the podocytes. The podocyte is 
phenotypically and functionally a sophisticated cell governed by a highly organized 
cytoskeleton. Podocytes play a critical role in the initiation and progression of 
proteinuric kidney diseases. The reorganization of podocyte cytoskeleton causing foot 
process effacement is a key factor in the development of proteinuria. Better 
understanding of the molecular composition and the biological interactions in these 
cells is a necessity for future specific targeted therapies.  
This study is based on a previous genome-wide approach aimed to characterize the 
transcriptome of the renal glomerulus through large-scale sequencing and microarray 
profiling. In reference to other well characterized podocyte-specific proteins, the 
rationale was to identify and characterize novel podocyte-specific proteins that show a 
similar restricted expression profile outside the glomerulus. In the papers, several such 
proteins are described.  
In paper I, sult1b1 was localized exclusively in the podocyte Golgi apparatus and 
ankrd25 was localized to podocyte foot processes as shown by RT-PCR, Western 
blotting and immunofluorescence stainings.  
In Paper II, pdlim2 was localized to podocyte foot processes as shown by RT-PCR, 
Western blotting, immunofluorescence and immunoelectron microscopy. In cultured 
podocytes, pdlim2 seemed to regulate actin dynamics. In addition, using Co-
immunoprecipitation experiments, pdlim2 was shown to interact with α-actinin-4 and 
amotl1. In semi-quantitative immunoelectron microscopy, there was a reduced 
expression of pdlim2 in podocytes of patients with certain proteinuric renal diseases.  
In Paper III: hip1, nfasc and olfml2a were localized exclusively in podocyte major 
processes as shown with RT-PR, Western blotting, immunofluorescence stainings and 
immunoelectron microscopy. During glomerulogenesis, the proteins were colocalized 
with a major processes marker vimentin as shown by immunofluorescence double 
stainings. The expression of hip1, olfml2a and pdlim2 was observed in glomerular 
crescents indicating the presence of podocytes in these lesions.  
In PaperIV, gprc5b was expressed exclusively by podocytes as shown with RT-
PCR, Western blotting, immunofluorescence and immunoelectron microscopy. Gprc5b 
knockdown in zebrafish exhibited classical features associated with loss of glomerular 
function such as pericardial edema and dilated Bowman’s capsule. Thus, gprc5b is 
essential for an intact glomerular filtration barrier.  
 
 
 
 
 
 
 
 
LIST OF PUBLICATIONS 
 I. 
 
 
 
 
 II.  
 
 
 
 
III. 
 
 
 
 
 
 
IV.  
 
 
 
 
 
 
 
 
Xu X, Patrakka J, Sistani L, Uhlen M, Jalanko H, Betsholtz C, Tryggvason K: 
Expression of novel podocyte-associated proteins sult1b1 and ankrd25. 
Nephron Exp Nephrol, 117(2):e39-46, 2011. 
 
 
Sistani L, Dunér F, Udumala S, Hultenby K, Uhlen M, Betsholtz C, Trygvason 
K, Wernerson A, Patrakka J: Pdlim2 is a novel actin-regulating protein of 
podocyte foot processes. Kidney International, 80(10):1045-54, 2011. 
 
 
Sistani L, Rodriguez P, Hultenby K, Uhlen M, Betsholtz C, Jalanko H, 
Tryggvason K, Wernerson A, Patrakka J: Huntingtin interacting protein 1, 
neurofascin and olfactomedin-like 2a are novel components of podocyte major 
processes and demonstrate the presence of podocytes in glomerular crescents. 
Submitted, 2012. 
 
 
Rodriguez P, Sistani L, Oddsson A, He B, Hultenby K, Ebrasi L, Betsholtz C, 
Wernerson A, Tryggvason K, Patrakka J: Gprc5b is required for the integrity of 
glomerular filtration barrier. Manuscript, 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE OF CONTENTS 
1  INRODUCTION .....................................................................................................1 
1.1  Renal anatomy and physiology ............................................................................................................ 1 
1.2  The nephron ................................................................................................................................................ 2 
1.2.1  Dynamics of ultrafiltration........................................................................................................................... 3 
1.3  The glomerular filter................................................................................................................................ 4 
1.3.1  The glomerular endothelium ..................................................................................................................... 5 
1.3.2  The glomerular basement membrane.................................................................................................. 6 
1.3.2.1  Laminin........................................................................................................................................................... 6 
1.3.2.2  Type IV collagen ...................................................................................................................................... 7 
1.3.2.3  Heparan sulfate proteoglycans .................................................................................................... 8 
1.3.2.4  Nidogen/entactin ..................................................................................................................................... 8 
1.3.3  The podocyte ......................................................................................................................................................... 9 
1.3.3.1  Cell Body: transcription factors .................................................................................................11 
1.3.3.2  Podocyte processes ...........................................................................................................................12 
1.3.3.3  Foot processes: apical surface ..................................................................................................13 
1.3.3.4  Foot processes: slit diaphragm .................................................................................................13 
1.3.3.5  Foot processes: basal surface....................................................................................................16 
1.3.3.6  Foot processes: actin cytoskeleton........................................................................................18 
1.4  Glomerulopathy .......................................................................................................................................20 
1.4.1  Idiopathic nephrotic syndrome ..............................................................................................................21 
1.4.1.1  Membranous nephropathy ..............................................................................................................21 
1.4.1.2  Minimal change nephrotic syndrome .......................................................................................22 
1.4.1.3  Focal segmental glomerulosclerosis..........................................................................................22 
1.4.2  The podocyte is a clear candidate for therapy in proteinuria.............................................23 
2  AIMS OF THE STUDY...........................................................................................24 
3  RESULTS AND DISCUSSION.................................................................................25 
3.1  Paper I: Expression of novel podocyte‐associated proteins sult1b1 and ankrd25........25 
3.1.1  Expression of sult1b1 in the glomerulus...........................................................................................25 
3.1.2  Expression of ankrd25 in the glomerulus ........................................................................................26 
3.2  Paper II: pdlim2 is a novel actin‐regulating protein of podocyte foot processes............27 
3.2.1  Expression of pdlim2 in the glomerulus............................................................................................27 
3.2.1.1  The role of pdlim2 in actin dynamics........................................................................................28 
3.2.1.2  Differential expression of pdlim2 in disease........................................................................29 
3.3  paper III: Huntingtin interacting protein 1, neurofascin and olfactomedin‐like 2a are 
novel components of podocyte major processes and demonstrate the presence of podocytes 
in glomerular crescents ....................................................................................................................................30 
3.3.1  Expression of hip1 in the glomerulus..................................................................................................30 
3.3.2  Expression of nfasc in the glomerulus ................................................................................................31 
3.3.3  Expression of olfml2a in the glomerulus ..........................................................................................32 
3.3.4  Expression of novel podocyte markers in glomerular crescents ......................................33 
3.4  paper IV: Gprc5b is required for the integrity of glomerular filtration barrier..............34 
3.4.1  Expression of gprc5b in the glomerulus............................................................................................34 
3.4.1.1  The role of gprc5b in the zebrafish pronephron ...............................................................35 
4  ACKNOWLEDGEMENTS...................................................................................... 37 
5  REFERENCES ...................................................................................................... 38 
 
LIST OF ABBREVIATIONS 
ALP 
Amotl1 
CD2AP 
CKD 
CNF 
ESL 
ESRD 
FSGS 
GAPDH 
GBM 
GFP 
GPCR 
hpf 
HSPG 
Ig 
ILK 
L1-CAM 
Lmx1b 
MN 
MCNS 
MO 
mRNA 
NERF2 
RT-PCR 
SD 
SRNS 
SULT 
TRPC6 
Wt1 
 
 
 
Actinin-associated LIM protein family 
Angiomotin-like 1 
CD2-associated protein 
Chronic kidney disease 
Congenital nephrotic syndrome of the Finnish type 
Endothelial surface layer 
End-stage renal disease 
Focal segmental glomerulosclerosis  
Glyceraldehyde 3-phosphate dehydrogenase 
Glomerular basement membrane 
Green fluorescent protein 
G-protein-coupled receptor 
Hours post fertilization 
Heparan sulfate proteoglycan 
Immunoglobulin 
Integrin-linked kinase 
L1-cell adhesion transmembrane 
LIM homeobox transcription factor 1-beta 
Membranous nephropathy 
Minimal change nephrotic syndrome 
Morpholino 
Messenger ribonucleic acid 
Na+/H+ exchanger regulatory factor 2 
Reverse transcript-polymerase chain reaction 
Slit diaphragm 
Steroid-resistant nephrotic syndrome 
Sulfotransferase 
Transient receptor potential channel 6 
Wilm’s tumor 1 
 
  1 
1 INRODUCTION 
1.1 RENAL ANATOMY AND PHYSIOLOGY 
References used for this section are medical physiology books (Bruce M. Koeppen 
2008; Gerard J.Tortora 2009; Rodney A. Rhoades 2009). 
 
The kidneys are paired organs lying outside the peritoneal cavity in the posterior part 
of the upper abdomen - one on each side of the vertebral column. The kidney has a 
bean-like shape with the medial border indented by a deep fissure called the hilus. This 
is where the blood vessels, lymphatics, nerves and ureter enter or leave the kidney. 
Each adult kidney weighs about 0.5 percent of total body weight corresponding to 
about 150 grams in adults.  
The kidney is considered the most important organ of excretion, eliminating the 
body’s metabolic waste products by filtering the blood from substances that are 
unwanted, or are in excess. The nephron is the functional unit of the kidney where the 
composition of blood is regulated through: filtration, secretion, reabsorption, and 
concentration. The kidneys receive about 20% (1.2 L/min) of the cardiac output 
through the renal arteries, which is an immediate branch of the abdominal aorta. The 
renal artery enters the kidney through the hilus and branches off to a network of smaller 
blood vessels that supply all parts of the kidney. 
The blood is filtered in the glomerular capillaries, and in 24 hours, about 180 liters 
of blood is filtered in the kidney. Most of the glomerular filtrate, also called primary 
urine, is reabsorbed by the tubular system of the nephron and returned to the systemic 
circulation through the renal vein that exits through the hilus and empties into inferior 
vena cava. The glomerular filtrate, or primary urine, is concentrated in the tubular parts 
of the nephron (Figure 1) into final urine, which is then excreted via the ureter into the 
bladder and expelled through the urethra.  
The kidneys selectively reabsorb important substances that are necessary to maintain 
the normal composition of the blood such as: amino acids, glucose, vitamins, minerals, 
ions, water, sodium, chloride, bicarbonate, potassium, magnesium, phosphate, and 
sulfate. By adjusting the blood composition, the kidneys are able to maintain blood 
volume and pressure, ensure proper balance of salts, electrolytes, acid-base, and pH 
levels. The kidneys also eliminate metabolic waste products, such as urea, uric acid, 
creatinine, and ammonia, as well as various toxins and drugs. In addition, the kidneys 
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serve as an endocrine organ releasing a variety of hormones including renin, 
erythropoietin, and calcitriol. Renin is involved in the regulation of blood pressure, 
sodium and potassium balance. Erythropoetin stimulates the production of erythrocytes 
in the bone marrow. Calcitriol, which is the active form of vitamin D, stimulates the 
uptake of calcium in the gastrointestinal tract, a necessary mineral for growth and 
remodelling of the bones.  
 
 
1.2 THE NEPHRON 
References used for this section are medical physiology books (Bruce M. Koeppen 
2008; Gerard J.Tortora 2009; Rodney A. Rhoades 2009). 
 
The nephron (Figure 1) is the basic unit of kidney structure and function that 
regulates the composition and volume of body fluids. Each human kidney is comprised 
of approximately one million nephrons. Each nephron consists of a renal corpuscle and 
a tubular system. The renal corpuscle is composed of a cluster of capillaries named the 
glomerulus (Figure 2), which is encased in a thin bag-like structure called Bowman’s 
capsule. The space inside the capsule and surrounding the glomerulus is called 
Bowmans’s space, or urinary space. The Bowman’s capsule continues into the 
proximal convoluted tubule, which is where the tubular system begins. This system is 
formed of various segments including the descending and ascending loop of Henle, 
distal convoluted tubule and collecting duct (Figure 1). 
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Figure 1 Schematic drawing of the nephron. Image source: The Bartleby.com edition of Grey's 
Anatomy of the Human Body from the classic 1918. 
 
 
 
 
1.2.1 Dynamics of ultrafiltration 
Each nephron is supplied with blood through the afferent arteriole, a subbranch of 
the renal artery, which give rise to the capillary tuft of the glomerulus. The glomerular 
capillaries then converge into the efferent arteriole where blood can exit the capsule to 
form a second capillary network that supply the nephron. The driving force for fluid 
filtration passing through the glomerulus is the Starling forces (the hydrostatic and 
colloid osmotic pressures). The arterial pressure forces fluid from the porous capillaries 
of the glomerulus across the filtration barrier into Bowman’s space. The composition of 
the glomerular filtrate is basically the plasma, excluding any significant amount of 
larger proteins. The plasma-like filtrate diffuses across Bowman’s space and travels 
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through the series of tubular segments of the nephron wherein the ultrafiltrate is 
effectively processed, and concentrated, through reabsorption and excretion into final 
urine. About 99% of the glomerular filtrate returns to the systemic circulation through 
tubular reabsorption and only 1-1.5 liter is excreted as urine.  
 
 
1.3 THE GLOMERULAR FILTER 
The plasma ultrafiltrate sieved through the glomerular capillary bed is almost 
exclusively free of cellular and macromolecular blood components. The composition of 
the plasma ultrafiltrate is based on size, charge and molecular configuration 
(Haraldsson and Sorensson 2004). For example, negatively charged high molecular 
weight proteins such as albumin are restricted from passing through the filtration 
membrane. 
The glomerular filtration barrier (Figure 3) is a highly complex biological structure, 
which is essentially composed of three main structures: 1) the glomerular basement 
membrane in the middle which serves as a foundation and support for; 2) fenestrated 
endothelial cells at the inside; and 3) the visceral epithelial cells (podocytes), located on 
the outside of the glomerular capillary facing the urinary space (Tryggvason and 
Wartiovaara 2001).  
The glomerulus contains a third cell type namely, mesangial cells (Figure 2). These 
cells are specialized vascular smooth muscle cells, some of which have phagocytic 
properties, and suggested to serve as the “pericytes of the glomerulus” (Schlondorff and 
Banas 2009). Mesangial cells reside between the capillary loops in the stalk of 
glomerulus, and provide support to maintain structure and stability to the glomerulus 
(Schlondorff and Banas 2009).  
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Figure 2 Schematic drawing of the kidney glomerulus. Image source: modified from Ross and 
Romell, 1989. 
 
 
 
 
1.3.1 The glomerular endothelium  
The glomerular endothelium forms the innermost layer of the filtration barrier. The 
endothelium is composed of flat cells containing round or ovoid transcellular holes, 60-
70 nm in diameter, named fenestrae (Avasthi and Koshy 1988). The large fenestrae 
allow for the extensive rate of exchange of water and low molecular weight waste 
products in the glomerulus (Bulger, Eknoyan et al. 1983; Satchell and Braet 2009). In 
mature glomeruli, the fenestrae do not seem to contain diaphragms (Ichimura, Stan et 
al. 2008), and occupy about 20-50% of total capillary surface area (Bulger, Eknoyan et 
al. 1983).   
The endothelial cells at the luminal side are coated with glycocalyx, a negatively 
charged gelatinous layer about 300 nm thick. The glycocalyx is composed of 
glycoproteins, proteoglycans, glycosaminoglycans, and trapped plasma proteins, which 
might possibly contribute to the charge-selective properties of the filtration barrier 
(Haraldsson, Nystrom et al. 2008; Satchell and Braet 2009). Several studies suggest the 
vital role of the endothelial cells and surface layer in the glomerular filtration barrier 
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where loss of anionic sites is associated with albuminuria (Gelberg, Healy et al. 1996; 
Jeansson and Haraldsson 2003; Bakker, Borghuis et al. 2005; Jeansson and Haraldsson 
2006). Similar effects have been reported in in vitro studies using monolayers of human 
glomerular endothelial cells. When disrupting the glycocalyx components, an increased 
albumin flux is observed (Singh, Satchell et al. 2007; Lennon, Singh et al. 2008) 
highlighting the important role of endothelial cell layer in charge-selectivity of the 
glomerular barrier.  
 
 
1.3.2  The glomerular basement membrane 
The glomerular basement membrane (GBM) is a specialized extracellular matrix 
and a crucial element of the filtration barrier that provides structural support for both 
podocytes and endothelial cells. During development, endothelial cells and podocytes 
synthesize separate basement membranes which later fuse to form the unusually thick, 
300-350 nm, GBM (Abrahamson 1987; Gubler 2008). As observed in electron 
microscopy, the mature GBM is subdivided into three layers; starting from base of 
endothelial cells the layers are termed, lamina rara interna followed by lamina densa in 
the middle, and lamina rara externa in the outer aspect (Abrahamson 1987). The major 
components of the GBM include laminin, type IV collagen, heparan sulfate 
proteoglycans, and nidogen (Gubler 2008). 
 
 
1.3.2.1 Laminin 
 
Laminins belong to a large family of heterotrimeric glycoproteins present in all 
basement membranes. They assemble into different (αβγ) isoforms providing a 
structural function in basement membranes (Miner 2008). Laminins are signaling 
molecules and play an essential role in organogenesis (Durbeej 2010). During 
glomerulogenesis, the laminin isoforms found in the GBM are LM-111 (α:1β:1γ:1) and 
LM-511 (α:5β:1γ:1). As the glomerulus develops the fetal laminins are entirely 
replaced with the mature isoform, LM-521 (α:5β:2γ:1) (Miner 1998). Laminin 
networks are connected to type IV collagen networks via nidogen providing structural 
support to the capillary wall (Timpl 1996). Mutations in laminin have been associated 
with proteinuria and nephrotic syndrome both in mouse and human. The autosomal 
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recessive disorder, Pierson syndrome, is caused by mutation in LAMB2 gene encoding 
the laminin β2 chain. Piersons syndrome displays diffuse mesangial sclerosis and 
congenital nephrotic syndrome (Zenker, Aigner et al. 2004). Laminin β2 knockout 
mice show proteinuria, foot process effacement, and die one month of age (Miner, Go 
et al. 2006). Podocyte-specific mutation in laminin α5 causes proteinuria in mice, 
which can progress to renal failure (Goldberg, Adair-Kirk et al. 2010). The above 
reports indicate the important role of laminins in the glomerular filtration barrier 
function.  
 
 
1.3.2.2 Type IV collagen 
 
Type IV collagen is a trimer composed of three α-chains arranged in a triple helix 
molecule. Type IV collagen is exclusively found in the basement membranes wherein 
the trimers cross-link and assemble into a polymeric network (Yurchenco 2011). The 
cross-linked molecular structure of collagen IV serves as a scaffold where other 
molecules such as laminins, perlecans, and proteoglycans can interact (Yurchenco 
2011). There are six different genes, COL4A 1- COL4A6, encoding six distinct collagen 
α-chains (α1(IV) - α6(IV)) in humans (Khoshnoodi, Pedchenko et al. 2008). During 
glomerulogenesis the type IV collagen of glomerular basement membrane is formed by 
the triple helix α1.α1.α2. Similar to laminins in the GBM, the embryonic type IV 
collagen is gradually replaced to the mature type IV collagen α3.α4.α5 (Hudson, 
Tryggvason et al. 2003).  
Mutations in COL4A3, COL4A4, and COL4A5 genes cause renal disease such as 
Alport’s syndrome, which is clinically characterized by hematuria, mild albuminuria, 
progressive renal disease and hearing impairment (Barker, Hostikka et al. 1990; 
Hudson, Tryggvason et al. 2003). Histopathological observations of kidney biopsies in 
Alport’s syndrome patients may first reveal a thinner GBM than normal, however, as 
the disease progress the GBM is thickened into multilamellations known as GBM 
splitting, which is present along with podocyte foot process effacement, glomerular 
scarring and interstitial fibrosis (Hudson, Tryggvason et al. 2003; Cosgrove, Kalluri et 
al. 2007).  
Type IV collagen α3-knockout mice display a similar renal phenotype as observed 
in Alport syndrome including GBM abnormalities and podocytopathy (Cosgrove, 
Meehan et al. 1996; Miner and Sanes 1996). Given that no significant proteinuria was 
  8 
observed in type IV collagen deficient patients/animals, type IV collagen does not seem 
important in the charge- and size-permselectivity of the filtration barrier. Nevertheless, 
it seemingly has a contributing role in maintaining the structural integrity of the 
glomerular filtration barrier.  
 
 
1.3.2.3 Heparan sulfate proteoglycans 
 
Heparan sulfate proteoglycans (HSPGs) are glycoproteins that consist of a core 
protein with covalently linked glycosaminoglycan side chains such as heparan sulfate 
and chondrotin sulfate. HSPGs present in basement membranes include, perlecan, agrin 
and collagen XVIII (Sarrazin, Lamanna et al. 2011). The glycosaminoglycan side 
chains are sulfated and negatively charged contributing to the anionic properties of 
GBM. Perlecan and collagen XVIII are predominantly expressed during 
glomerulogenesis (Saarela, Rehn et al. 1998; Groffen, Veerkamp et al. 1999), whereas 
the mature GBM is primarily composed of agrin (Groffen, Ruegg et al. 1998). 
 Podocyte-specific agrin knockout mice show reduction in GBM anionic sites but do 
not develop proteinuria (Harvey, Jarad et al. 2007). Similarly, perlecan deficient mice 
show no proteinuria or renal abnormalities, although they show increase susceptibility 
to protein-overload proteinuria (Morita, Yoshimura et al. 2005). Collagen XVIII mutant 
mice show increased mesangial matrix and elevated creatinine levels in the kidney 
(Utriainen, Sormunen et al. 2004). Moreover, double mutant agrin and perlecan mice 
develop and maintain a normal filtration barrier (Goldberg, Harvey et al. 2009). Despite 
the reduction of GBM anionic charge in these mice no structural abnormality of the 
filtration barrier or proteinuria was detected which indicate that the negative charge of 
the GBM is not the primary barrier as it was initially suggested.  
 
 
1.3.2.4 Nidogen/entactin 
 
Nidogens-1 and nidogen-2, also known as entactin, are glycoproteins that are widely 
expressed in basement membranes and bind to collagen IV, perlecan and laminin 
(Yurchenco and Patton 2009). Nidogen-1 and -2 are both components of the GBM. 
Nidogen links laminin and type IV collagen forming a ternary complex, which is the 
reason nidogen was considered to be required for basement membrane development 
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(Salmivirta, Talts et al. 2002). However, nidogen-1 and -2 single and double knockout 
mice develop a normal GBM and only show a mild phenotype in certain basement 
membranes (Bader, Smyth et al. 2005).  
 
 
 
1.3.3 The podocyte 
The podocytes constitute the third layer of the glomerular filter and are attached to 
the GBM on the outer aspect of the glomerular capillary. Podocytes are highly 
specialized cells with a remarkably sophisticated architecture and a corresponding well-
developed cytoskeleton (Pavenstadt, Kriz et al. 2003). Morphologically and 
functionally the podocyte is subdivided into three major parts: cell body, major 
processes and foot processes. The podocyte has a large cell body, a prominent nucleus 
and well-developed organelles. The cell body expands to form large cytoplasmic 
projections named primary processes (Pavenstadt, Kriz et al. 2003). A single podocyte 
is able to spread out with its processes over several loops of glomerular capillaries.  
The primary processes further divide and form numerous smaller projections known 
as foot processes. The podocyte foot processes of the neighboring cells interdigitate and 
cover the loops of capillaries (Pavenstadt, Kriz et al. 2003). The interdigitating foot 
processes are bridged by specialized cell-cell contacts and form the slit diaphragm 
(SD). The SD is a dynamic multiprotein structure critical for a sustained filtration 
barrier function (Tryggvason and Wartiovaara 2005; Tryggvason, Patrakka et al. 2006). 
Furthermore, the podocyte is supported by a well-organized cytoskeleton. Bundles of 
microtubules and intermediate filaments support the major processes, whereas the 
cytoskeleton of foot processes is composed of actin filaments (Drenckhahn and Franke 
1988; Pavenstadt, Kriz et al. 2003).  
Initially, the GBM was thought to be the principal charge- (Deen, Lazzara et al. 
2001) (Tryggvason and Wartiovaara 2005) and size-selective barrier (Caulfield and 
Farquhar 1974; Kanwar, Liu et al. 1991). However, this view changed with the 
discovery of the first molecular component of the SD, nephrin. In 1998, Tryggvason 
and colleagues identified mutations in nephrin in patients suffering from congenital 
nephrotic syndrome of the Finnish type  (CNF) (Kestila, Lenkkeri et al. 1998). With the 
discovery of nephrin, podocyte biology entered a new era as it gained an increasing 
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research interest. It is now well recognized that podocytes play a central role in 
glomerular filtration process (Leeuwis, Nguyen et al. 2010).  
Several podocyte proteins have been identified to be essential for the normal 
glomerular filtration function. These proteins include components of the SD: podocin 
(Boute, Gribouval et al. 2000), Neph1 (Donoviel, Freed et al. 2001), FAT1 (Inoue, 
Yaoita et al. 2001), and TRPC6 (Winn, Conlon et al. 2005), linker proteins connecting 
the SD to the podocyte cytoskeleton including CD2-associated protein (CD2AP) (Shih, 
Li et al. 1999), and Nck (Jones, Blasutig et al. 2006), as well as actin-associated 
proteins synaptopodin (Deller, Merten et al. 2000), and α-actinin-4 (Kaplan, Kim et al. 
2000).  
Podocytes are terminally differentiated epithelial cells with limited ability to 
regenerate upon injury (Mathieson 2012). Podocytes play a critical role in the 
ultrafiltration process and are involved in the initiation and progression of proteinuric 
kidney diseases (Mathieson 2012). The identification of podocyte genes causing 
glomerular kidney disease has provided valuable insight into understanding the role of 
podocytes in the glomerular filtration function (Tryggvason, Patrakka et al. 2006). 
 
 
 
Figure 3 Schematic drawing of the glomerular filtration barrier composed of the fenestrated 
endothelium, the GBM and a layer of podocyte foot processes. The two neighboring podocyte foot 
processes are connected via a complex of proteins forming the SD. Image source: modified from 
Patrakka and Tryggvason, 2009. 
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1.3.3.1 Cell Body: transcription factors 
 
Wt1 
Mutations in the gene Wt1 that encodes the tumor suppressor Wilm’s tumor 1 (Wt1) 
cause Frasier syndrome and Denys-Drash syndrome (Pelletier, Bruening et al. 1991; 
Klamt, Koziell et al. 1998). Wt1 is a transcription factor essential for normal 
genitourinary development regulating numerous genes involved in cellular 
differentiation (Lee and Haber 2001). However, in the adult kidney, Wt1 is present only 
in podocytes indicating the importance of Wt1 in maintaining podocyte differentiation 
(Schedl and Hastie 2000). Mutations in Denys-Drash syndrome occur in the zinc finger 
encoding exons affecting DNA binding affinity; while in Frasier syndrome mutations in 
intron nine alter the proportion of two alternatively spliced Wt1 transcripts (Barbaux, 
Niaudet et al. 1997; Kikuchi, Takata et al. 1998; Klamt, Koziell et al. 1998; Lee and 
Haber 2001).  
Patients with Denys-Drash syndrome exhibit early nephrotic syndrome including 
diffuse mesangial sclerosis with rapid development into renal failure, male 
pseudohermaphroditism, and Wilm’s tumor (Pelletier, Bruening et al. 1991; Niaudet 
and Gubler 2006). Patients with Frasier syndrome develop gonadoblastoma, nephrotic 
syndrome caused by focal segmental glomerulosclerosis (FSGS) and progressing renal 
failure (Gubler, Yang et al. 1999; Koziell and Grundy 1999). Wt1 has been reported to 
regulate the expression of podocyte proteins such as podocalyxin and nephrin (Palmer, 
Kotsianti et al. 2001; Guo, Morrison et al. 2004; Wagner, Wagner et al. 2004). 
 
 
Lmx1b 
Mutations in the Lmx1b gene that encodes LIM homeobox transcription factor 1β 
(Lmx1b) cause the autosomal dominant disorder nail-patella syndrome. The phenotypic 
characteristics of the disease include: skeletal malformations, nail dysplasia, patellar 
abnormalities, nephropathy and glaucoma (Dreyer, Zhou et al. 1998; Vollrath, 
Jaramillo-Babb et al. 1998; Bongers, Huysmans et al. 2005). Renal disease is seen in 
40% of nail-patella syndrome patients, and it is an important factor in predicting the 
prognostic outcome. The pathological changes observed in nephrotic syndrome are a 
thicker, discontinuous GBM with fibrillar collagen inclusions and foot process 
effacement (Rascle, Suleiman et al. 2007).  
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Lmx1b knockout mice show similar phenotypic characteristics seen in nail-patella 
syndrome as well as lack of foot processes and SD formation (Chen, Lun et al. 1998; 
Miner, Morello et al. 2002; Rohr, Prestel et al. 2002). However, Lmx1b heterozygous 
mice (the genotype in nail-patella patients) do not present a podocyte phenotype (Rohr, 
Prestel et al. 2002). Several important podocyte genes have been shown to be 
dysregulated in these mice including podocin, CD2AP and type IV collagen. Although, 
it is worth mentioning that the dysregulation of these genes have not been reported in 
nail-patella patients (Suleiman, Heudobler et al. 2007).  
 
 
1.3.3.2 Podocyte processes 
 
The podocyte primary/major processes are large cytoplasmic projections of the cell 
body. The major processes, unlike the cell body, almost lack organelles but have an 
abundant cytoskeleton composed of microtubules, and intermediate filaments such as 
vimentin (Drenckhahn and Franke 1988; Pavenstadt, Kriz et al. 2003); however, the 
molecular nature of major processes is still poorly understood. On the other hand, the 
foot processes are composed of a dense network of actin filaments connecting the 
neighboring foot processes (Faul, Asanuma et al. 2007).  
The plasma membrane of foot processes is subdivided into three compartments 
including the apical, slit diaphragm and basal surfaces, which are connected via a 
number of linker proteins and the actin cytoskeleton (Oh, Reiser et al. 2004; Patrakka 
and Tryggvason 2009). The reorganization of podocyte foot process cytoskeleton in 
pathological conditions is known as foot process effacement, which is often observed in 
proteinuric renal diseases (Oh, Reiser et al. 2004). While the molecular composition of 
podocyte foot processes is well characterized (Patrakka and Tryggvason 2009), a 
missing focus in the podocyte field is on the role of major processes and its molecular 
composition in renal diseases. The differences in the morphology of the primary and 
the foot processes indicate an obvious molecular and functional divergence between 
these structures.  
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1.3.3.3 Foot processes: apical surface 
 
Podocalyxin 
The apical and lateral surfaces of podocyte foot processes have a negative charge 
contributing to the overall negative charge of the glomerular filtration barrier. The 
abundant expression of podocalyxin, a sialyated and sulfated transmembrane protein is 
responsible for the negative charge present in podocytes (Nielsen and McNagny 2009). 
During development, podocalyxin is first present only at the apical surface of podocyte 
foot processes, and as the podocyte differentiates, podocalyxin expression migrates 
along the lateral surfaces above the slit diaphragm. Podocalyxin has been reported to 
have antiadhesive properties that maintain the filtration slits open through charge 
repulsion (Schnabel, Dekan et al. 1989).  
Experimental studies suggest the essential role of podocalyxin in the filtration slit 
structure and function. Although podocalyxin deficient mice have podocytes, they fail 
to form foot processes and slit diaphragms. These mice also show severe kidney 
defects, anuric renal failure and neonatal lethality (Doyonnas, Kershaw et al. 2001). 
Podocalyxin has been shown to associate to actin filaments through interaction with the 
PDZ-containing protein, Na+/H+ exchanger regulatory factor 2 (NERF2) (Takeda, 
McQuistan et al. 2001), and the linker protein ezrin (Orlando, Takeda et al. 2001). The 
disruption of podocalyxin/NERF2/ezrin complex has been shown in pathological 
conditions associated with foot processes effacement, suggesting an important role of 
these proteins in disease (Takeda, McQuistan et al. 2001). 
 
 
1.3.3.4 Foot processes: slit diaphragm  
 
Podocyte foot processes of neighboring cells interdigitate and connect through 
specialized cell-cell contacts known as slit diaphragm (SD) (Tryggvason and 
Wartiovaara 2005). In the 1970s Karnovsky and colleagues first described the SD as a 
zipper-like structure. It was suggested to contain a central band between two 
neighboring foot processes that were bridged by even spaced filaments forming a 
porous size-selective structure (Rodewald and Karnovsky 1974). At present, the SD is 
considered to be a three dimensional structure composed of a complex of proteins that 
may resemble a dynamic sieve-like structure with small pores that are 5-15 nm in size, 
as suggested by Karnovsky and colleagues (Jefferson, Nelson et al. 2011). Besides 
  14 
contributing to the structure of filtration barrier, the slit diaphragm proteins have an 
important role in podocyte signaling, and connect to the podocyte cytoskeleton 
machinery (Pavenstadt, Kriz et al. 2003; Faul, Asanuma et al. 2007).   
 
 
Nephrin 
Mutations in the NPHS1 gene that encodes nephrin cause congenital nephrotic 
syndrome of the Finnish type (CNF), highlighting the crucial role of nephrin and the 
SD in the glomerular filteration barrier function (Tryggvason and Wartiovaara 2001). 
CNF is an autosomal recessive disorder characterized by absence of SD between 
podocyte foot processes, and massive proteinuria in utero (Lenkkeri, Mannikko et al. 
1999). Similarly, the genetic deletion of nephrin in mice causes massive proteinuria, 
foot process effacement and early death (Putaala, Soininen et al. 2001; Rantanen, 
Palmen et al. 2002).  
Nephrin is a 180-kDa transmembrane protein belonging to the immunoglobulin 
family of cell adhesion molecules. It is thought that nephrin molecules from adjacent 
foot processes interact in the SD and perhaps in that way form the filter structure 
proposed by Karnovsky and colleagues (Rodewald and Karnovsky 1974; Khoshnoodi, 
Sigmundsson et al. 2003). Besides providing structural function, nephrin is thought to 
participate in signal transduction by phosphorylation of tyrosine residues present in the 
intracellular domain. Nephrin is also associated with mechanisms regulating the 
podocyte actin dynamics (Zenker, Machuca et al. 2009). For example, nephrin is 
tyrosine phosphorylated by Fyn kinase leading to interaction with nck and subsequently 
stimulating actin polymerization (Verma, Kovari et al. 2006). Experimental studies 
with Fyn and nck deficient mice were shown to develop a compromised filtration 
barrier (Yu, Yen et al. 2001; Jones, New et al. 2009).   
 
 
Podocin 
Mutations in the NPHS2 gene that encodes podocin was identified to be the cause of 
autosomal recessive steroid-resistant nephrotic syndrome (SRNS) characterized by 
early onset nephrotic syndrome with resistance to steroid therapy and fast progression 
to end-stage renal disease (ESRD) (Boute, Gribouval et al. 2000). Podocin is an integral 
membrane protein exclusively expressed in podocytes. It is a 42-kDa protein that has a 
hairpin-like transmembrane domain and cytosolic N- and C-terminal domains 
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(Horinouchi, Nakazato et al. 2003). Podocin is localized in the SD where it has been 
shown to interact with other SD proteins such nephrin, CD2AP and Neph1 (Huber, 
Kottgen et al. 2001; Schwarz, Simons et al. 2001; Sellin, Huber et al. 2003). Podocin is 
thought to serve as a scaffold protein essential to maintain the structural integrity of slit 
diaphragm (Schwarz, Simons et al. 2001). Podocin deficient mice present a severe 
phenotype including foot process fusion, deficient formation of SD, proteinuria, and 
perinatal lethality (Roselli, Heidet et al. 2004). 
 
 
Neph1 
Neph1 is a nephrin-like transmembrane protein of the immunoglobulin superfamily 
and it has been localized in the SD (Donoviel, Freed et al. 2001). Deletion of neph1 in 
mice has been reported to cause proteinuria, foot process effacement, and early 
postnatal death suggesting an important role in maintaining the structure of the 
filtration barrier (Donoviel, Freed et al. 2001). Neph1 has been reported to interact with 
both nephrin and podocin in the SD (Barletta, Kovari et al. 2003; Sellin, Huber et al. 
2003). Furthermore, neph1 interacts with the nephrin-Nck signaling pathway involved 
in actin polymerization (Garg, Verma et al. 2007), which could explain the cause of the 
renal phenotype similar to that observed in nephrin and podocin deficiencies.   
 
 
Fat1 
Fat1 is a large transmembrane protein of the cadherin superfamily characterized by 
multiple repeats of the cadherin motif and cell adhesion properties (Suzuki 1996; Inoue, 
Yaoita et al. 2001). Fat1 has been localized to the SD and deletion of Fat1 in mice 
results in lack of SD formation, foot process effacement, and perinatal lethality, 
indicating an important role in SD development and maintaining the structure of 
filtration barrier (Cai, Liu et al. 2000). These mice also show defective eye and brain 
development. Fat1 has been shown to interact with ZO-1, a tight junction protein 
associated with the slit diaphragm (Inoue, Yaoita et al. 2001). Fat1 has been reported to 
regulate cell-cell adhesion by controlling actin dynamics (Tanoue and Takeichi 2004). 
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TRPC6 
Transient receptor cation channel 6 (TRPC6) belongs to the TRP superfamily of ion-
channel forming proteins involved in Ca2+ transport into the cell (Schlondorff and 
Pollak 2006). In the kidney, TRPC6 has shown to have a broad expression pattern 
wherein the glomerulus, expression is found in all three cell types; mesangial and 
endothelial cells, as well as in podocytes as a component of the SD, and major 
processes (Reiser, Polu et al. 2005; Winn, Conlon et al. 2005) (Schlondorff and Pollak 
2006). Mutations in TRPC6 gene have been reported to cause autosomal dominant 
focal segmental glomerulosclerosis type 2 (FSGS2) characterized by proteinuria and 
glomerular lesions (Reiser, Polu et al. 2005; Winn, Conlon et al. 2005). The mutations 
in TRPC6 have shown gain-of-function properties leading to increased levels of Ca2+ 
influx and defective cytosolic signaling. TRPC6 has been associated with the podocyte 
actin cytoskeleton wherein overexpression of TRPC6 was reported to induce actin 
cytoskeleton rearrangement (Moller, Wei et al. 2007). 
 
 
1.3.3.5 Foot processes: basal surface 
 
Integrin 
Podocyte foot processes are attached to the GBM through cell-matrix adhesion 
molecules such as integrins and dystroglycans (Mundel and Shankland 2002). Integrins 
are αβ heterodimeric transmembrane proteins that mediate cell-cell and cell-matrix 
communication, and provide a link between extracellular matrix and the cytoskeleton 
(Lowell and Mayadas 2012). The major integrin at the sole of podocyte foot processes 
is α3β1 heterodimer. α3β1 integrins mediate interaction with the GBM through 
laminin, type IV collagen and fibronectin (Adler 1992). α3β1 also provide a link 
between the intracellular cytoskeleton and the GBM via paxillin, talin, vinculin, α-
actinin and filamin (Faul, Asanuma et al. 2007).  
The important role of integrins in filtration barrier function has been reported in 
several studies. For example, deletion of α3 in mice has been reported to cause 
abnormal kidney development including defective glomerular capillaries, thickening 
and fragmentation of the GBM, lack of foot processes in podocytes, and perinatal death 
(Kreidberg, Donovan et al. 1996). Furthermore, podocyte-specific α3-deficient mice 
develop massive proteinuria accompanied by partially sclerosed glomeruli, 
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disorganized GBM and foot process effacement (Sachs, Kreft et al. 2006). In addition, 
podocyte-specific β1-deficient mice exhibit a severe glomerular phenotype including 
GBM abnormalities, foot processs effacement, massive proteinuria, and neonatal death 
(Kanasaki, Kanda et al. 2008; Pozzi, Jarad et al. 2008).  
Integrin-linked kinase (ILK) is an intracellular protein kinase that provides a link 
between the GBM and podocytes. Podocyte-specific ILK deficiency in mice has been 
reported to cause progressive FSGS, proteinuria, foot process effacement, GBM 
abnormalities, and renal failure, suggesting the important role of molecules mediating 
GBM-podocyte adhesion in glomerular filtration function (Dai, Stolz et al. 2006; El-
Aouni, Herbach et al. 2006).  
 
 
Dystroglycan 
Dystroglycan, another class of αβ heterodimeric cell-adhesion transmembrane 
molecule, has also been localized at the sole of podocyte foot processes. Dystroglycan 
has been reported to interact to the GBM through laminin, agrin and perlecan, and to 
the intracellular cytoskeleton, through utrophin (Raats, van den Born et al. 2000; 
Regele, Fillipovic et al. 2000). The role of dystroglycans in podocyte and the 
glomerular filtration barrier function remains elusive.  
 
 
CD151 
The cell surface protein, CD151, is a member of tetraspanin superfamily. CD151 is 
ubiquitously expressed and associated with integrins (Rubinstein 2011). In the 
glomerulus, CD151 has been localized at the basal surface of podocyte foot processes 
binding to α3β1 integrin (Sterk, Geuijen et al. 2002). CD151-deficient patients show 
end-stage renal disease with focal thickening, and irregularities of the GBM, as well as 
skin lesions and hearing impairment (Karamatic Crew, Burton et al. 2004). CD151-null 
mice also show GBM fragmentation and thickening, focal glomerulosclerosis, 
proteinuria, and foot process effacement, suggesting the important role of CD15-α3β1 
integrin interaction in podocyte foot processes (Sachs, Kreft et al. 2006).  
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1.3.3.6 Foot processes: actin cytoskeleton 
 
The plasma membrane of foot processes is subdivided into three aspects, which are 
in contact via the cytoskeleton (Nishibori, Katayama et al. 2011). The cytoskeletal 
machinery plays a central role in maintaining the structural and functional integrity of 
the filtration barrier. The reorganization of the cytoskeleton is associated with foot 
process effacement, a compromised filtration barrier, and proteinuria (Faul, Asanuma et 
al. 2007). This is not a surprising phenomenon since the podocyte cytoskeletal 
machinery is central to podocyte morphology, which in turn is key to proper function. 
In fact, many SD components are either directly or indirectly linked to the actin 
cytoskeleton (Faul, Asanuma et al. 2007). Hence, proteins regulating or stabilizing 
actin dynamics and the podocyte cytoarchitecture are highly important for the integrity 
of the glomerular filter.  
 
 
α-actinin-4 
α-actinin is a cytoskeletal actin-binding protein that cross links and bundles actin 
filaments. It interacts with a variety of proteins connecting the actin cytoskeleton to the 
cell membrane and regulates the activity of a variety of receptors (Otey and Carpen 
2004). α-actinin-1 and α-actinin-4 are widely expressed and are the non-muscle 
(calcium sensitive) isoforms commonly associated with focal contacts and stress fibers 
(Sjoblom, Salmazo et al. 2008).  
α-actinin-4 is abundantly expressed in podocyte foot processes and plays an 
important role in maintaining the glomerular filtration barrier function. Mutations in the 
ACTN4 gene cause autosomal dominant FSGS, proteinuria, and progressing renal 
failure (Kaplan, Kim et al. 2000). Disease associated gene mutations have shown to 
cause, in part, a gain-of-function property resulting in a higher affinity to F-actin 
filaments (Kaplan, Kim et al. 2000; Weins, Kenlan et al. 2005), which could explain 
the podocytopathy and proteinuria observed in these patients. Furthermore, α-actinin-4 
knockout mice develop severe glomerular lesions, foot process effacement, and 
proteinuria (Kos, Le et al. 2003). 
 
 
 
  19 
 
Synaptopodin 
The actin-associated protein synaptopodin is exclusively present in two highly 
dynamic structures; the dendritic spines of neurons and podocyte foot processes 
(Deller, Merten et al. 2000). Synaptopodin gene expression in podocytes has been 
shown to be differentiation dependent and correlated with the formation of cell 
processes (Mundel, Heid et al. 1997). Synaptopodin interacts with α-actinin and 
regulates its actin-bundling activity (Asanuma, Kim et al. 2005). In addition, 
synaptopodin interacts to the cytoplasmic adaptor protein CD2AP, which in turn 
directly interacts with the SD proteins, nephrin and podocin (Schwarz, Simons et al. 
2001; Shih, Li et al. 2001; Huber, Kwoh et al. 2006). 
Synaptopodin deficient mice exhibit spine and synaptic abnormalities but no renal 
phenotype (Asanuma, Kim et al. 2005). However, these mice were unable to recover 
from induced nephrotic syndrome and foot process effacement. Similarly, gene 
silencing of synaptopodin in cultured podocytes showed impaired actin filament 
reformation (Asanuma, Kim et al. 2005). Synaptopodin has also been shown to be an 
upstream regulator of RhoA, inducing the formation of stress fibers and cell motility in 
cultured podocytes (Asanuma, Yanagida-Asanuma et al. 2006). RhoA belongs to the 
family of small GTPases involved in various cell signaling pathways and regulation of 
actin dynamics (Jaffe and Hall 2005). 
 
 
CD2AP 
The adaptor protein CD2AP was first identified as a ligand interacting with the T-
cell-adhesion protein CD2 (Wolf and Stahl 2003). In the kidney, CD2AP is primarily 
expressed in podocyte foot processes (Shih, Li et al. 1999). CD2AP knockout mice 
show a severe renal phenotype manifested as foot process effacement, proteinuria, and 
progressive glomerulosclerosis leading to kidney failure and death, suggesting a critical 
role in the glomerular filtration barrier function (Shih, Li et al. 1999; Li, Ruotsalainen 
et al. 2000). CD2AP heterozygous mice have an increased susceptibility to glomerular 
injury (Kim, Wu et al. 2003). In addition, CD2AP haploinsufficinecy has been 
identified in patients with FSGS nephrotic syndrome (Kim, Wu et al. 2003). TGF-β-
induced podocyte apoptosis has been associated with CD2AP insufficiency in mice, 
which could explain the pathomechanism and loss of podocytes observed in these 
animals (Schiffer, Mundel et al. 2004). CD2AP has been reported to interact with other 
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critical foot process proteins including nephrin, podocin and synaptopodin (Schwarz, 
Simons et al. 2001; Shih, Li et al. 2001; Huber, Kwoh et al. 2006). Thus, serving as a 
link between podocyte SD and foot process cytoskeleton.  
 
 
Nck 
Nck1 and nck2 are SH2/SH3 containing adaptor proteins implicated in tyrosine 
kinase-mediated signal transduction events that for instance involves regulation of actin 
dynamics (McCarty 1998). Nck1 or nck2 show overlapping and mutually 
compensatory functions, as mice lacking either nck1 or nck2 are viable without any 
renal phenotype (Bladt, Aippersbach et al. 2003). However, deletion of both nck genes 
was shown to cause embryonic lethality (Bladt, Aippersbach et al. 2003). In podocytes, 
nck proteins are localized in the cytoplasmic face of foot processes. Podocyte-specific 
nck1 and nck2 knockout mice displayed a similar renal phenotype observed in nephrin 
deficient mice, which include failure to form foot processes, proteinuria, glomerular 
lesions, as well as growth abnormalities (Jones, Blasutig et al. 2006). Nck has been 
reported to interact with the cytoplasmic tyrosine-containing domain of nephrin (Jones, 
Blasutig et al. 2006). Nephrin is tyrosine phosphorylated by Fyn kinase and subsequent 
interaction with nck stimulating actin polymerization. This could explain the renal 
phenotype similar to nephrin deletion (Tryggvason, Pikkarainen et al. 2006; Verma, 
Kovari et al. 2006; Jones, New et al. 2009). 
 
 
 
1.4 GLOMERULOPATHY 
A large amount of renal disorders are caused by injury to the glomerulus. 
Glomerulopathy may be due to primary renal disease where pathology is observed only 
in the glomerulus i.e., Immunoglobulin (Ig) A glomerulopathy (Lai 2012), or it may be 
secondary to a systemic disorder where multiple organs are affected as in diabetic 
nephropathy and lupus glomerulonephritis (Stitt-Cavanagh, MacLeod et al. 2009; 
Tsokos 2011). Glomerulopathies are broadly classified as nephritic or nephrotic 
syndrome. Nephritic syndrome is caused by inflammatory effects that are often 
associated with hematuria, mild protenuria, hypertension, and decreased glomerular 
filtration rate (Moller, Pollak et al. 2006). On the other hand, nephrotic syndrome is 
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associated with massive proteinuria (>3.5 g protein/24 hours), hypoalbuminemia, 
edema, lipidemia and lipiduria (Jefferson, Nelson et al. 2011).  
Proteinuria is the hallmark of glomerular disease often observed with foot process 
effacement, indicating a compromised filtration barrier (Patrakka and Tryggvason 
2009). In a healthy individual only a small amount of albumin is lost in the final urine 
(Haraldsson and Sorensson 2004). The increased level of excreted albumin in the range 
of 30-300 mg/24 hours reflects microalbuminuria, whereas proteinuria is confirmed 
when urine excretes more than 300 mg of protein per day (Haraldsson, Nystrom et al. 
2008). Proteinuria is caused by a variety of glomerular diseases; although most 
proteinuria syndromes are acquired, it is well known that genetic defects in the 
molecular components of podocyte foot processes or SD play a major role in many 
human hereditary proteinuria syndromes (Tryggvason, Patrakka et al. 2006). The 
identification and characterization of rare monogenic glomerular kidney diseases have 
provided valuable information in understanding the physiopathology of the glomerular 
filtration process (Mundel and Shankland 2002).  
 
 
1.4.1 Idiopathic nephrotic syndrome 
Three distinct histological variants of primary idiopathic nephrotic syndrome exist:  
membranous nephropathy (MN), minimal change nephrotic syndrome (MCNS), and 
focal segmental glomerulosclerosis (FSGS) (Wei and Reiser 2011). A common 
denominator in all three disease forms is injury to podocytes. Corticosteroid and 
immunosuppressive drug therapy is the main treatment in these patients, however, a 
significant proportion of patients do not respond to therapy (Eddy and Symons 2003).  
 
 
1.4.1.1 Membranous nephropathy 
 
MN is the most common cause of idiopathic nephrotic syndrome in adults, although 
in some patients it may be secondary to infection, drugs and toxic substances or other 
diseases such as autoimmune diseases, diabetes mellitus, and cancer (Ponticelli 2007). 
The disease exhibits a spectrum of severity and a majority of patients may have 
spontaneous remission or partial remission, whereas a considerable proportion with 
severe proteinuria progress toward end-stage renal disese (ESRD) within 5 to 15 years 
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(Nangaku, Shankland et al. 2005). MN is characterized by the in situ formation of 
immune-complex deposits located between the GBM and podocytes causing a 
membrane-like thickening of the glomerular capillary wall (Cybulsky 2011). The 
immune-complexes are formed locally due to a reaction between a circulating antibody 
and podocyte antigen (Ponticelli 2007). These immune-complexes trigger inflammation 
and complement activation and induce podocyte injury such as foot process effacement 
(Nangaku, Shankland et al. 2005). 
 
 
 
 
1.4.1.2 Minimal change nephrotic syndrome 
 
MCNS is the most common cause of idiopathic nephrotic syndrome in children and 
is clinically characterized by rapid onset of proteinuria (Eddy and Symons 2003). The 
usual presenting complaint in these patients is facial edema and abdominal distension 
(Tune and Mendoza 1997). The histology of glomeruli appear normal on light 
microscope despite the presence of massive proteinuria, however, electron microscopy 
of kidney biopsies show extensive foot process effacement (Chugh, Clement et al. 
2012). The morphology of the GBM remains unchanged although reduced anionic 
charge has been reported (Chugh, Clement et al. 2012). The majority of MCNS patients 
respond to therapy, however, a high rate of relapse is present (Eddy and Symons 2003). 
Renal biopsy in these patients is only required if they do not respond to steroids, and in 
that case, one of the likely histological diagnosis is FSGS (Mathieson 2007).  
 
 
1.4.1.3 Focal segmental glomerulosclerosis 
 
FSGS is a major cause of ESRD (Daskalakis and Winn 2006). The initial clinical 
presentation may overlap to that observed in MCNS. FSGS is a subtype of idiopathic 
nephrotic syndrome (Meyrier 2005), however, deficiencies of several podocyte proteins 
(mentioned earlier) including nephrin, podocin, α-actinin-4, TRPC6 and CD2AP cause 
hereditary forms of FSGS and nephrotic syndrome. FSGS is not a disease but a 
pathological lesion observed first in the glomerulus that progress to other parts of the 
renal tissue (Meyrier 2005). The pathological diagnosis is characterized by the presence 
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of segmental collagenous sclerotic lesions in some glomeruli where only a part of the 
glomerulus is affected, hence the name focal segmental (Deegens, Steenbergen et al. 
2008). Glomerular sclerosis is observed in a variety of kidney diseases and FSGS is 
considered to have a multifactorial etiology.  
FSGS often presents a heterogeneous phenotype, however, proteinuria is detected in 
all FSGS patients indicating a compromised filtration barrier (Reidy and Kaskel 2007). 
Nephrotic FSGS is considered to be a disease associated with podocyte injury leading 
to decreased number of podocytes (Crosson 2007). The main treatment therapy in 
FSGS patients is corticosteroid and immunosuppressive drugs (Meyrier 2005). 
However, the majority of FSGS patients do not respond to therapy and can progress to 
chronic renal insufficiency (Wei and Reiser 2011). Recurrence of nephrotic syndrome 
and glomerular lesions is present in about 30% of renal transplants (Meyrier 2004).  
  
 
 
1.4.2 The podocyte is a clear candidate for therapy in proteinuria  
Glomerulopathies are a major cause of chronic kidney disease (CKD) that can 
progress to end-stage renal disease (ESRD). ESRD, with an increasing prevalence, is a 
significant cause of morbidity and mortality worldwide (Ruggenenti, Schieppati et al. 
2001; Daskalakis and Winn 2006). ESRD can only be treated with continuous dialysis 
or renal transplantation (Leeuwis, Nguyen et al. 2010). In addition to poor clinical 
outcome, CKD and ESRD patient-care is a tremendous burden on healthcare budgets 
(Rastogi, Linden et al. 2008).  
Considering the magnitude of the problems associated with CKD and ESRD it is 
essential to establish novel therapeutics aimed at the cellular level. As podocyte 
dysfunction has a crucial role in the initiation and progression of glomerulopathies, it 
clearly is a candidate for therapy in proteinuria (Patrakka and Tryggvason 2009; 
Mathieson 2012).  
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2 AIMS OF THE STUDY 
This study is based on a previous genome-wide approach aimed to characterize the 
transcriptome of the renal glomerulus through large-scale sequencing and microarray 
profiling (Takemoto, He et al. 2006). More than 300 highly glomerulus-enriched 
transcripts were identified. In the thesis several of these transcripts were further 
characterized. The specific aims of the project are: 
 
Paper I: To characterize the role of novel podocyte proteins sult1b1 and ankrd25 in 
the glomerular filtration barrier function 
 
Paper II: To characterize the role of novel podocyte protein pdlim2 in the glomerular 
filtration barrier function 
 
Paper III: To characterize the role of novel podocyte proteins hip1, nfasc and olfml2a 
in the glomerular filtration barrier function  
 
Paper IV: To characterize the role of novel podocyte protein gprc5b in the glomerular 
filtration barrier function 
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3 RESULTS AND DISCUSSION 
It is known that several podocyte proteins essential for the glomerular filtration 
barrier function, such as nephrin, podocin and synaptopodin, show a very restricted 
expression pattern outside of the podocyte (Patrakka and Tryggvason 2010). With this 
in mind, we were primarily interested in identifying podocyte-associated proteins, 
which had not been previously reported in the glomerulus, and displayed a similar 
restricted expression pattern in the kidney and outside of the glomerulus. The table 
below includes the list of proteins identified in this study. In the thesis the proteins will 
be referred to by the abbreviated version.  
 
 
Table I List of proteins described in the papers 
Name Abbreviation 
Sulfotransferase family 1B, member 1 sult1b1 
KN motif and ankyrin repeat domains 2   ankrd25 
PDZ and LIM domain 2  pdlim2 
Huntingtin interacting protein 1 hip1 
Neurofascin nfasc 
Olfactomedin-like 2A olfml2a 
G protein-coupled receptor family C, group 5, member B  gprc5b 
 
 
 
3.1 PAPER I: EXPRESSION OF NOVEL PODOCYTE-ASSOCIATED 
PROTEINS SULT1B1 AND ANKRD25 
 
3.1.1 Expression of sult1b1 in the glomerulus 
Sult1b1 is a member of the cytosolic sulfotransferase (SULT) protein family 
(Hildebrandt, Carrington et al. 2007). These enzymes transfer sulfate groups to specific 
molecules. Sulfotransferases are classified in two families: 1) the cytosolic SULTs 
involved in metabolism of drugs, steroids, bile acids and neurotransmitters, and 2) 
membrane-bound SULTs found in the Golgi apparatus which are involved in 
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sulfonation of peptides, proteins, lipids and glycosaminoglycans (Gamage, Barnett et 
al. 2006). Previous studies have reported the expression of sultlb1 in the liver, intestine 
and leukocytes (Dombrovski, Dong et al. 2006).  
In this study, the expression of sult1b1 transcript in various mouse tissues was 
analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR). Sult1b1 
expression was observed in the liver, the brain and the glomerulus, whereas no 
expression was observed in the rest of the kidney fraction devoid of glomeruli. By 
using the polyclonal antibodies produced against the corresponding human protein we 
could further analyse the expression in the kidney. Using immunofluorescence staining 
in normal adult human kidney sections, sult1b1 was detected in the glomerular tuft, and 
no obvious positive signal was detected in the extraglomerular areas.  
In Western blotting of human kidney lysates, several bands (∼120, ∼65, ∼55, and 
∼35) were observed in the glomerular fraction, whereas no reactivity was observed in 
the kidney fraction lacking glomeruli. The predicted size of sult1b1 protein is ∼35 kDa 
(www.ensembl.org) corresponding to the smallest protein recognized by our antibody. 
The subcellular distribution of sult1b1 protein was analyzed by double staining with 
Golgi marker, GM130. Colocalization revealed sult1b1 as a novel component of 
podocyte Golgi apparatus. Based on the restricted expression pattern of sult1b1, we 
speculate that this enzyme has a dedicated role in the podocytes; it could be involved in 
sulfonylation of podocyte proteins such as podocalyxin, a highly sulfated and 
abundantly expressed protein in the podocytes. Podocalyxin is, as mentioned earlier, 
essential for maintaining the architectural integrity of foot processes and filtration 
barrier (Takeda, Go et al. 2000). 
 
 
3.1.2 Expression of ankrd25 in the glomerulus 
Ankrd25, also known as kank2, is member of a family of proteins (kank1-4) that 
contain N- terminal coiled-coil motifs and C-terminal ankyrin repeats (Sarkar, Roy et 
al. 2002). Ankyrin-repeats are highly conserved motifs mediating protein-protein 
interactions (Sedgwick and Smerdon 1999). The kank protein family has been shown to 
be involved in the regulation of actin polymerization and cell motility, and they have 
been associated with cancer, neuronal and developmental disorders (Kakinuma, Zhu et 
al. 2009).  
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 In a previous report, the expression of ankrd25 was observed in all human tissues 
that were analyzed, in which the detected expression levels were highest in cervix, 
colon, heart, kidney and lung tissues (Zhu, Kakinuma et al. 2008). The ubiquitous 
expression pattern of the ankrd25 was also observed in our RT-PCR results. Concurrent 
with our microarray data (Takemoto, He et al. 2006), in Western blotting of human 
kidney lysate, a band of the size ∼120 kDa was detected in the glomerular fraction. 
However, a very weak signal was detected in the rest of the kidney fraction.  
Using immunofluorescence staining, a closer examination of ankrd25 expression 
pattern in the kidney showed expression in podocytes, mesangial and vascular smooth 
muscle cells. In the podocyte, ankrd25 was shown to partially colocalize with nephrin, 
indicating localization in the foot processes. In light of the fact that, the cytoskeletal 
machinery of podocytes play a key role in glomerular filtration barrier integrity, and the 
previously reported role of ankrd25 in the regulation of actin dynamics, we speculate 
that ankrd25 may play a role in regulating actin dynamics in podocyte foot processes. 
 
 
 
3.2 PAPER II: PDLIM2 IS A NOVEL ACTIN-REGULATING PROTEIN OF 
PODOCYTE FOOT PROCESSES 
 
3.2.1 Expression of pdlim2 in the glomerulus 
Pdlim2, also known as mystique, is a member of the actinin-associated LIM protein 
(ALP) family, which contain one N-terminal PDZ domain and one C-terminal LIM 
domain (Te Velthuis, Isogai et al. 2007). PDZ-LIM containing proteins are highly 
conserved scaffold proteins that mediate protein-protein interactions. These proteins are 
involved in a wide range of important biological processes including: cytoskeletal 
organization, organogenesis, and neuronal signaling (te Velthuis and Bagowski 2007).  
In this study, we identified pdlim2 as a novel molecular component of podocyte foot 
processes. The expression of pdlim2 transcript in the kidney glomerulus in comparison 
to the rest of the kidney was confirmed by RT-PCR. At the protein level, the expression 
was confirmed with Western blotting of human kidney lysates and immunostainings. In 
Western blotting, a band of the size ∼40 kDa was detected in the glomerular fraction, 
while no band was observed in the rest of the kidney fraction. The subcellular 
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localization of pdlim2 in podocytes was shown with immunofluorescence staining and 
immunoelectron microscopy. 
In immunofluorescence staining of adult human kidney sections, a strong positive 
signal was detected in the glomerular tuft, whereas no signal was observed outside the 
glomeruli. Double staining with synaptopodin (foot process protein) and phalloidin 
(detecting actin) showed colocalization in foot processes; however, no colocalization 
was observed when double staining with vimentin (a marker for major processes). 
Localization of pdlim2 in the glomerulus by immunoelectron microscopy was observed 
in the cytosol of foot processes. Gold particles were mainly found in the cytoskeleton, 
observed as electron-dense areas. In addition, double labelling of pdlim2 and 
synaptopodin showed a close localization of these two proteins in the foot processes. 
 
 
3.2.1.1 The role of pdlim2 in actin dynamics 
 
Previously, pdlim2 has been suggested to act as an adaptor allowing for the 
interaction of various proteins involved in actin cytoskeleton (Torrado, Senatorov et al. 
2004). In line with this, we suggest that pdlim2 is a novel actin-regulating molecule of 
podocyte foot processes. This was shown in cultured podocytes where pdlim2 was 
associated with stress fibers and cortical actin. The association of pdlim2 with stress 
fibers was investigated by transfecting differentiated human podocytes (Saleem, O'Hare 
et al. 2002) with full-length pdlim2, and treating them with latrunculin A at various 
concentrations. Latrunculin A is a drug that disrupts the actin cytoskeleton by 
preventing the repolymerization of actin monomers into filaments (Morton, Ayscough 
et al. 2000). Upon latrunculin A treatment, the pdlim2-positive cells displayed intact 
stress fibers in comparison to pdlim2-negative cells. This observation was better visible 
with an increasing concentration of latrunculin A. The loss of stress fibers caused 
significant changes in cell morphology; thus, pdlim2 stabilized actin structures in 
podocytes and promoted the maintenance of intact cell morphology under pathological 
stimulus. 
To characterize the functional role of pdlim2 in actin dynamics and uncover 
interacting partners we performed the yeast two-hybrid screen. Two proteins associated 
with actin dynamics and identified in pdlim2 yeast two-hybrid screen, α-actinin-4 
(Kaplan, Kim et al. 2000) and angiomotin-like 1 (amotl1) (Gagne, Moreau et al. 2009), 
were further investigated. Double staining experiments in cultured podocytes revealed 
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colocalization of pdlim2 with α-actinin-4 and amotl1 in stress fibers. Double staining 
of adult human kidney sections with amotl1 and α-actinin-4 showed colocalization 
with pdlim2. Furthermore, pdlim2 interaction with α-actinin-4 and amotl1 was 
confirmed with co-immunoprecipitation experiments in double-transfected HEK293 
cells. As mentioned earlier, mutations in the α-actinin-4 gene has been associated with 
foot process effacement and proteinuria (Kaplan, Kim et al. 2000).  
We speculate that pdlim2 is likely to be linked in these disease processes as it 
directly interacts with α-actinin-4 and regulates actin dynamics in podocytes. Similarly, 
Amotl1 may be involved in the regulation of actin dynamics in podocyte foot 
processes. Of note, we initially analyzed the renal phenotype of a pdlim2-deficient 
mouse line, and the animals did not show any clear glomerular abnormalities 
(unpublished data). 
 
 
3.2.1.2 Differential expression of pdlim2 in disease 
 
The expression of pdlim2 in biopsies of human proteinuric diseases including 
minimal change nephrotic syndrome (MCNS), membranous nephropathy (MN), and 
focal segmental glomerulosclerosis (FSGS) was examined by semi-quantitative 
immunoelectron microscopy. The expression of pdlim2 in FSGS patients was 
unchanged compared to controls, although extensive foot process effacement was 
present. On the other hand, pdlim2 expression was significantly decreased in MN and 
MCNS patient biopsies. Thus, pdlim2 may be a useful diagnostic marker for MCNS as 
the differential diagnosis between FSGS and MCNS can be difficult in the clinic due to 
the overlapping histopathological features observed in both diseases (Eddy and Symons 
2003).  
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3.3 PAPER III: HUNTINGTIN INTERACTING PROTEIN 1, NEUROFASCIN 
AND OLFACTOMEDIN-LIKE 2A ARE NOVEL COMPONENTS OF 
PODOCYTE MAJOR PROCESSES AND DEMONSTRATE THE 
PRESENCE OF PODOCYTES IN GLOMERULAR CRESCENTS 
 
3.3.1 Expression of hip1 in the glomerulus 
Hip1 has previously been studied mostly in the brain. It is known to be an endocytic 
adaptor protein involved in clathrin-mediated vesicle trafficking with the ability to bind 
to actin (Legendre-Guillemin, Wasiak et al. 2004; Wilbur, Chen et al. 2008). In 
addition, hip1 is present in a complex with glutamate receptors, and studies in knockout 
animals have shown that hip1 facilitates glutamate signaling (Metzler, Li et al. 2003). 
We have identified hip1 as a novel component of podocyte major processes. The 
expression of the transcript was confirmed with RT-PCR in the glomerulus as opposed 
to the rest of the kidney. At the protein level, the expression was confirmed with 
Western blotting of human kidney tissue samples and immunostainings.  
In Western blotting, a band of the size ∼115 kDa was detected in the glomerular 
fraction, while no band was observed in the rest of the kidney fraction. In 
immunofluorescence staining of adult human kidney sections, a strong positive signal 
was detected in the glomerular tuft and no signal was detected in the extraglomerular 
areas. Overlapping double staining with vimentin, a marker for major processes 
suggests the localization of hip1 to major processes. In line with this, the majority of 
gold particles (55%) observed in immunoelectron microscopy experiments were 
located in the major processes.  
To further analyze the expression of hip1 in the glomerulus and the association to 
major processes in development we used immunofluorescence staining in developing 
human kidney sections. Hip1 expression was observed in the capillary stage 
glomerulus, whereas no expression was observed in the earlier developmental stages, 
vesicle and S-shape glomerulus. Throughout the development of podocytes, the 
staining for hip1 colocalized with the major process marker vimentin. The capillary 
stage glomerulus is, in fact, the time at which the formation of major processes starts, 
which supports the idea that hip1 is associated with major processes. Previously, 
glutamate signaling has been reported to have a crucial role in podocytes (Giardino, 
Armelloni et al. 2009), and hip1 could be linked to the glutamate signaling machinery. 
However, our findings are conflicting with the fact that: 1) glutamate signaling is 
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associated with the podocyte slit diaphragm, and not major processes, and 2) the 
expression of other glutamate signaling proteins have so far not been observed in 
immature podocytes (Giardino, Armelloni et al. 2009). In this respect, we speculate that 
hip1 may have a role, separate from that of glutamate signaling pathway in podocytes. 
Hip1 may be linked to the prominent cytoskeletal machinery that governs the podocyte 
integrity. Of note, we initially analyzed the renal phenotype of hip1 knockout mice 
(Metzler, Li et al. 2003), and the animals did not show any overt renal phenotype 
(unpublished data). 
 
 
3.3.2 Expression of nfasc in the glomerulus 
Nfasc has previously been thought to be specific for the neuronal tissues where three 
major isoforms: NF155, NF166, and NF186 have been identified (Sherman, Tait et al. 
2005). Nfasc is a member of L1 cell adhesion transmembrane molecules (L1-CAMs) 
(Herron, Hill et al. 2009). The cytoplasmic portion of these proteins has the ability to 
bind to the cytoskeletal protein ankyrin (Herron, Hill et al. 2009). In addition, the 
cytoplasmic tail of nfasc has been shown to bind to doublecortin, a microtubule 
binding/stabilizing protein (Kizhatil, Wu et al. 2002). Notably, mutation in the 
drosophila ortholog of nfasc impairs the assembly of microtubules in neurons 
(Godenschwege, Kristiansen et al. 2006). Consistent with this, nfasc deficient mice die 
soon after birth and display severe defects in the formation of axons (Sherman, Tait et 
al. 2005). 
We have identified nfasc as a novel component of podocyte major processes. The 
expression of the transcript was confirmed with RT-PCR in the glomerulus as opposed 
to the rest of the kidney. At the protein level, the expression was confirmed with 
Western blotting of human kidney tissue samples and immunostainings. In Western 
blotting, a band of the size ∼185 kDa was detected in the glomerular fraction, while no 
band was observed in the rest of the kidney fraction.  
In immunofluorescence staining of adult human kidney sections, a strong positive 
signal was detected in the glomerular tuft and no signal was detected in the 
extraglomerular areas. Overlapping staining with vimentin, a marker for major 
processes, suggest the localization of hip1 to major processes. In immunofluorescense 
staining of developing kidney sections, nfasc expression was first observed at the 
capillary loop stage glomerulus wherein it colocalized with vimentin. No signal was 
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observed in the earlier stages, vesicle and S-shape glomerulus. These findings support 
the idea that nfasc associates with major processes, and could play a role in the 
microtubular dynamics of these cellular projections, similarly to that seen in drosophila 
(Godenschwege, Kristiansen et al. 2006). Of note, we have identified a nfasc-binding 
protein, doublecortin, in major processes (unpublished data), and at present, we are 
generating a podocyte-specific knockout mouse line to elucidate the functional role of 
nfasc in the kidney.  
 
 
3.3.3 Expression of olfml2a in the glomerulus 
Olfml2a is a member of olfactomedin domain containing proteins predicted to be a 
secreted protein associated with the plasma membrane (Tomarev and Nakaya 2009). 
We have identified olfml2a as a novel component of podocyte major processes. The 
expression of the transcript was confirmed with RT-PCR in the glomerulus as opposed 
to the rest of the kidney. At the protein level, the expression was confirmed with 
Western blotting of human kidney tissue samples and immunostainings. In Western 
blotting, a band of the size ∼110 kDa was detected in the glomerular fraction, while no 
band was observed in the rest of the kidney fraction.  
In immunofluorescence staining of adult human kidney sections, a strong positive 
signal was detected in the glomerular tuft while no signal was detected in the 
extraglomerular areas. Overlapping double staining with vimentin, a marker for major 
processes suggests the localization of olfml2a to major processes. Consistent with this, 
in immunoelectron microscopy experiments, the majority of gold particles (85%) were 
found in major processes. In immunofluorescence staining of developing kidney 
sections, olfml2a expression was not detected at the early vesicle stage glomerulus. At 
S-shape glomerulus, olfml2a was detected in the invading endothelial cells; however, 
olfml2a was not observed at a later stage in maturing glomerular endothelial cells. 
Olfml2a was first detected in the podocytes of the developing capillary loop stage, 
where it colocalized with vimentin. In accordance with this, overlapping expression of 
vimentin and olfml2a at the maturing stage glomerulus was detected at the apical 
aspects of podocytes. The above findings support the idea that olfml2a is associated 
with major processes both in developing and mature podocytes.  
The molecular function of olfml2a is poorly understood. In a previous study, the 
olfactomedin domain of gliomedin has been shown to have the ability to bind to 
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neurofascin in Nodes of Ranvier of neurons, and contributing to the stabilization of 
these structures (Eshed, Feinberg et al. 2005). As olfml2a contains one olfactomedin 
domain, it is possible that this sort of interaction and functional similarities occurs in 
podocytes. Olfml2a, neurofascin and doublecourtin may form a protein complex in 
major processes and stabilizing microtubular structures. Similarly to nfasc, a limitation 
to conduct molecular functional studies of olfml2a is the lack of its expression in 
immortalized podocyte cell lines.  
 
 
3.3.4 Expression of novel podocyte markers in glomerular crescents 
Crescentic lesions are often observed in inflammatory diseases affecting the 
glomerulus and are in general indicative of severe injury (Singh, Jeansson et al. 2011). 
These are characterized as a heterogenous composition of cells and matrix including: 
leukocytes, renal cells, and fibrin. The cellular composition of crescents has been 
unclear due to the presence and role of podocytes in these lesions (Singh, Jeansson et 
al. 2011). While some studies have reported the presence of podocytes in glomerular 
crescents (Moeller, Soofi et al. 2004; Thorner, Ho et al. 2008), other studies have 
reported the contrary (Nitta, Horita et al. 1999; Patrakka, Ruotsalainen et al. 2001; 
Usui, Kanemoto et al. 2003). 
To gain further insight into this question, we used these novel podocyte markers in 
immunohistochemistry of crescentic human renal biopsies. Hip1 (14/26 crescents) and 
olfml2a (21/31 crescents) were detected in most cellular crescents. Of note, no reliable 
signal was detected with two different anti-nfasc antibodies. Previously, we reported 
pdlim2 as a novel component of podocyte foot processes (ref. paper II). Since pdlim2 is 
expressed earlier than other well-characterized foot process markers such as nephrin 
and synaptopodin, we used pdlim2 as a positive marker. Pdlim2 expression was 
observed in 30/43 cellular crescents identified. Thus, in this report, the glomerular 
crescents expressed three podocyte-specific markers providing further evidence for the 
presence of podocytes in these lesions. 
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3.4 PAPER IV: GPRC5B IS REQUIRED FOR THE INTEGRITY OF 
GLOMERULAR FILTRATION BARRIER 
 
3.4.1 Expression of gprc5b in the glomerulus 
Gprc5b is a member of the mammalian superfamily of G-protein-coupled receptors 
(GPCRs) (Brauner-Osborne and Krogsgaard-Larsen 2000). G-protein signaling is 
involved in many well-characterized cellular pathways; hence, molecules that affect 
GPCR pathways are widely used in drug therapy (Wess 1998). Podocytes express 
numerous GPCR, including receptors that are critical in the biology and disease of 
podocytes (Pavenstadt, Kriz et al. 2003). 
Previously, the pathogenic role of G-protein signaling in podocytes has been 
reported using genetically modified mouse model strategies (Asanuma, Kim et al. 
2005; Chen, Overcash et al. 2011; Boucher, Yu et al. 2012). In this report, we have 
identified a novel highly podocyte-specific GPCR. The expression of gprc5b transcript 
in mouse and zebrafish glomerulus was confirmed using RT-PCR. No signal was 
detected in the rest of the kidney devoid of glomeruli. At the protein level, the 
expression of gprc5b was confirmed with Western blotting of human kidney tissue 
samples and immunostainings. 
In Western blotting, two bands of the sizes ∼45 kDa and ∼50 kDa were detected in 
the glomerular fraction, while no band was observed in the rest of the kidney fraction. 
However, the signal for the band of the size ∼45 kDa was significantly stronger. In 
immunofluorescence staining of adult human kidney sections, a strong positive signal 
was detected in the glomerular tuft, while no signal was detected in the extraglomerular 
areas. Overlapping double staining with nephrin suggests the localization of gprc5b to 
foot processes; though, some signal was detected at the apical aspects of podocyte foot 
processes. Concurrent with immunofluorescence stainings, in immunoelectron 
microscopy experiments, the majority of gold particles (∼90%) were localized to 
podocytes. In podocytes, gold particles were predominantly found within the apical 
membrane and the SD.  
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3.4.1.1 The role of gprc5b in the zebrafish pronephron 
 
The zebrafish model was used to study the functional role of gprc5b in the 
glomerulus. Using RT-PCR, two gprc5b ortholos (sgprc5b and ptgprc5b) were detected 
in the zebrafish pronephros. However, sgprc5b showed a “pronephros-specific” 
expression pattern, similar to that observed for gprc5b in human glomerulus. The 
expression of sgprc5b in pronephros was similar to the expression of nephrin in the 
glomerulus, whereas, ptgprc5b expression was detected in both of the tissue samples, 
pronephros and the rest of fish devoid of pronephros. At the protein level, the 
expression of gprc5b was confirmed in Western blotting of zebrafish tissue samples. A 
band of the size ∼35 kDa was detected in the pronephros fraction, while no band was 
observed in the control lane. 
The role of gprc5b in the glomerulus was investigated by knocking down the 
expression of sgprc5b in zebrafish pronephros with antisense morpholino (MO) oligos. 
Severe cardiac edema was observed in 49% of the embryos that were injected with the 
morpholino (MO). This phenotype was first observed 72 h post-fertilization, the time 
point at which pronephros is functional. Pericardial edema in embryos injected with 
control MO was observed in only 6% of cases. Rescue experiments in zebrafish by co-
injecting sgprc5b MO along with synthetic human gprc5b mRNA showed normal 
morphology, without any pericardial edema in 68% of cases as opposed to 51% 
observed in cases injected with only MO. A closer examination of the histology of the 
pronephros in gprc5b morphants showed expanded Bowman’s space. In electron 
microscopic analysis, similar expansion of the urinary space was detected. In addition, 
the podocyte foot processes were highly disorganized and seemingly infiltrating the 
basement membrane.  
To further evaluate the effect of gprc5b knockdown in podocytes, we used a 
transgenic zebrafish line that expresses green fluorescence protein (GFP) from the 
zebrafish podocin promoter (He, Ebarasi et al. 2011). GFP expression in these fish is 
normally detected in 86% of the cases; however, injection of sgprc5b MO in these fish 
resulted in a reduced GFP expression to only 47% of the cases, indicating the 
occurrence of injury and/or the reduction of podocytes.  
Pericardial edema observed in sgprc5b morphants has previously been reported in 
nephrin and podocin morphants, which in zebrafish is a sign of a compromised 
glomerular function (Kramer-Zucker, Wiessner et al. 2005). In addition, the expansion 
of Bowman’s capsule is also a pathological feature found in nephrin and podocin 
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zebrafish morphants, as well as in many human proteinuric diseases. Podocytes express 
numerous GPCRs that are important in biology and disease (Pavenstadt, Kriz et al. 
2003). Several studies using genetically manipulated mouse models have provided 
evidence on the pathogenic role of G-protein signaling in podocytes (Asanuma, Kim et 
al. 2005; Xiao, He et al. 2011; Boucher, Yu et al. 2012). 
Interestingly, studies on knockout mice line gprc5a, which is a member of the same 
protein family as gprc5b, have shown that the deletion of this receptor cause the 
activation of NF-kB and STAT3 signaling pathway resulting in the formation of lung 
tumors (Chen, Deng et al. 2010; Deng, Fujimoto et al. 2010). Previous studies in 
transgenic mouse models have provided evidence that increased activation of NF-kB 
and STAT3 signaling in podocytes is associated with podocyte damage and progressive 
renal diseases (Chuang and He 2010). For example, the progression of diabetic 
nephropathy in mice heterozygous for STAT3 null allele is significantly slower than in 
wild type animals (Hussain, Romio et al. 2009; Lu, Wang et al. 2009; Wiggins, Patel et 
al. 2010).  
In this report, gprc5b knockdown in zebrafish exhibited classical features associated 
with loss of glomerular function. We hypothesize that gprc5b exerts an inhibitory effect 
on the NF-kB and STAT3 pathways in podocytes, and the podocyte injury observed in 
gprc5b morphants may be caused by the increased activation of these pathways. Thus, 
gprc5b is a potential target candidate for pharmacological intervention in proteinuric 
renal diseases as it provides the opportunity to manipulate these signaling pathways 
specifically in podocytes. 
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